In an attempt to determine the role of the fusion oncogene FUS-DDIT3 in the sensitivity to HSP90 inhibition, cell viability assays were also performed on the fibrosarcoma cell line HT1080 and the stably transfected HT1080-FUS-DDIT3-EGFP cell line. The gene discussed is DDIT3; the disease is fibrosarcoma.